All patients with opioid-related issues are study eligible except those who are not able to provide informed consent by the time of ED discharge.
Recruitment path
5
Patients are recruited when they are present in the ED or on an inpatient unit if they were admitted there from the ED.
Setting
4
The trial is occurring in university-affiliated teaching hospitals; however, the specific EDs do not regularly engage in research.
Organization intervention
3
The research grant provides the hospital with funding and resources to implement and run the intervention; however, the hospital employs and supervises PRCs.
Flex of experimental intervention delivery
3
PRCs are given guidelines for how to engage patients, but implementation of guidelines is not regularly monitored.
Flex of experimental intervention adherence
5
Patients are not expected to adhere to the intervention; rather, it is up to the PRCs to engage and motivate them.
Follow-up
5
All follow-up data collection is through existing administrative sources.
Outcome
5
Primary outcomes are (1) treatment linkage, (2) treatment engagement, (3) reduced overdose, and (4) reduced overdose mortality, which are all relevant to people in OUD recovery.
